The US FDA has approved the DermaCompare melanoma (skin cancer) diagnosis system developed by Israel’s Emerald Medical (formally DermaCare). The smartphone app enables tele-dermatology to detect possible melanomas and save lives.
http://www.globes.co.il/en/article-emerald-to-market-melanoma-diagnosis-system-in-us-1001112066